#46 – Frank Watanabe, President & CEO at Arcutis Biotherapeutics
Slice of Healthcare Team
10/30/2024
Details
In This Episode Patient-Centered Dermatology Innovations
Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics.
What you'll get out of this episode:
- Company Focus: Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending.
- Significant Milestones: This year, Arcutis launched two new products and partnered with a primary care company to expand its reach.
- Patient-Centric Approach: Arcutis prioritizes patient needs by involving dermatology practitioners and patient insights directly in decision-making.
- Technological Perspective: While acknowledging AI's potential in drug discovery, Arcutis is focused on tangible, current advancements without prematurely implementing AI.
- Expanding Accessibility: Arcutis is actively working to extend its treatments to Medicare and Medicaid markets to support a broader patient demographic.
Watch
Listen
